Tetrahydrobiopterin: Beyond Its Traditional Role as a Cofactor
Antioxidants · 03.05.2023 · 12 (5) · 1037
DOI: 10.3390/antiox12051037 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 03.05.2023. Verfasst von Tuany Eichwald und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Bioenergética e Estresse Oxidativo-LABOX, Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Santa Cat…. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina, CHOC Foundation.
Abstract (Originalsprache)
Tetrahydrobiopterin (BH4) is an endogenous cofactor for some enzymatic conversions of essential biomolecules, including nitric oxide, and monoamine neurotransmitters, and for the metabolism of phenylalanine and lipid esters. Over the last decade, BH4 metabolism has emerged as a promising metabolic target for negatively modulating toxic pathways that may result in cell death. Strong preclinical evidence has shown that BH4 metabolism has multiple biological roles beyond its traditional cofactor activity. We have shown that BH4 supports essential pathways, e.g., to generate energy, to enhance the antioxidant resistance of cells against stressful conditions, and to protect from sustained inflammation, among others. Therefore, BH4 should not be understood solely as an enzyme cofactor, but should instead be depicted as a cytoprotective pathway that is finely regulated by the interaction of three different metabolic pathways, thus assuring specific intracellular concentrations. Here, we bring state-of-the-art information about the dependency of mitochondrial activity upon the availability of BH4, as well as the cytoprotective pathways that are enhanced after BH4 exposure. We also bring evidence about the potential use of BH4 as a new pharmacological option for diseases in which mitochondrial disfunction has been implicated, including chronic metabolic disorders, neurodegenerative diseases, and primary mitochondriopathies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratório de Bioenergética e Estresse Oxidativo-LABOX, Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Florianópolis 88037-100, SC, Brazil.
- Laboratory for Energy Metabolism, Division of Metabolic Disorders, CHOC Children's Hospital, Orange, CA 92868, USA.
- Neuroinflammation Group, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW 2109, Australia.
ORCID-Profile: Ananda Christina Staats Pires, Gilles J Guillemin
Förderung
- National Council for Scientific and Technological Development
- Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina
- CHOC Foundation
- CNPq
- FAPESC
Zitieren
APA
Eichwald, T., da Silva, L. B., Staats Pires, A. C., Niero, L., Schnorrenberger, E., Filho, C. C., Espíndola, G., Huang, W. L., Guillemin, G. J., Abdenur, J. E., & Latini, A. (2023). Tetrahydrobiopterin: Beyond Its Traditional Role as a Cofactor. Antioxidants, 12(5), 1037. https://doi.org/10.3390/antiox12051037
Vancouver
Eichwald T, da Silva LB, Staats Pires AC, Niero L, Schnorrenberger E, Filho CC, et al. Tetrahydrobiopterin: Beyond Its Traditional Role as a Cofactor. Antioxidants. 2023;12(5):1037. doi:10.3390/antiox12051037
BibTeX
@article{Eichwald2023,
author = {Eichwald, Tuany and da Silva, Lucila de Bortoli and Staats Pires, Ananda Christina and Niero, Laís and Schnorrenberger, Erick and Filho, Clovis Colpani and Espíndola, Gisele and Huang, Wei-Lin and Guillemin, Gilles J and Abdenur, José E and Latini, Alexandra},
title = {Tetrahydrobiopterin: Beyond Its Traditional Role as a Cofactor},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {5},
pages = {1037},
doi = {10.3390/antiox12051037}
}
EUVIMED